MEATTINI, ICRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.121
EU - Europa 13.051
AS - Asia 11.645
SA - Sud America 1.784
Continente sconosciuto - Info sul continente non disponibili 480
AF - Africa 329
OC - Oceania 162
AN - Antartide 1
Totale 48.573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.666
RU - Federazione Russa 4.412
IT - Italia 3.547
CN - Cina 3.126
SG - Singapore 3.024
HK - Hong Kong 1.527
PL - Polonia 1.443
BR - Brasile 1.418
VN - Vietnam 1.201
KR - Corea 1.001
IE - Irlanda 929
SE - Svezia 689
BD - Bangladesh 548
FR - Francia 498
DE - Germania 428
FI - Finlandia 388
IN - India 357
CA - Canada 273
GB - Regno Unito 230
ID - Indonesia 162
AU - Australia 159
JO - Giordania 156
AR - Argentina 142
JP - Giappone 115
NL - Olanda 96
ES - Italia 93
UA - Ucraina 80
MX - Messico 77
NG - Nigeria 69
EC - Ecuador 67
TR - Turchia 67
IQ - Iraq 62
CH - Svizzera 47
ZA - Sudafrica 46
MA - Marocco 43
PK - Pakistan 41
VE - Venezuela 40
CI - Costa d'Avorio 37
CO - Colombia 35
BE - Belgio 31
UZ - Uzbekistan 26
EG - Egitto 25
SA - Arabia Saudita 25
PY - Paraguay 23
CR - Costa Rica 20
PE - Perù 20
AE - Emirati Arabi Uniti 19
AT - Austria 19
BJ - Benin 19
CZ - Repubblica Ceca 19
JM - Giamaica 19
KE - Kenya 19
KZ - Kazakistan 19
MY - Malesia 19
TN - Tunisia 19
CL - Cile 18
DZ - Algeria 17
IL - Israele 16
AZ - Azerbaigian 15
NP - Nepal 15
PH - Filippine 15
UY - Uruguay 15
LT - Lituania 14
BG - Bulgaria 13
DO - Repubblica Dominicana 12
TH - Thailandia 12
SC - Seychelles 11
AL - Albania 10
HN - Honduras 10
PT - Portogallo 10
TW - Taiwan 10
LB - Libano 9
BH - Bahrain 8
GT - Guatemala 8
HU - Ungheria 7
OM - Oman 7
PA - Panama 7
RO - Romania 7
SN - Senegal 7
SV - El Salvador 7
RS - Serbia 6
SY - Repubblica araba siriana 6
GE - Georgia 5
GR - Grecia 5
MM - Myanmar 5
SK - Slovacchia (Repubblica Slovacca) 5
BY - Bielorussia 4
CY - Cipro 4
DK - Danimarca 4
KG - Kirghizistan 4
PR - Porto Rico 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AO - Angola 3
BB - Barbados 3
BO - Bolivia 3
ET - Etiopia 3
EU - Europa 3
HR - Croazia 3
KH - Cambogia 3
Totale 48.041
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.513
Ashburn 2.732
Singapore 2.239
Fairfield 1.707
Warsaw 1.430
Hong Kong 1.317
Seoul 995
Dublin 926
Hefei 859
San Jose 806
Seattle 791
Woodbridge 782
Chandler 772
Houston 683
Milan 674
Cambridge 671
Wilmington 585
Council Bluffs 509
Beijing 482
Ho Chi Minh City 403
Los Angeles 365
Lawrence 363
Altamura 360
Buffalo 344
Ann Arbor 318
Rome 314
Florence 305
Hanoi 280
Lauterbourg 259
Moscow 258
Princeton 257
The Dalles 236
New York 221
Helsinki 198
Munich 184
Boston 178
Paris 156
Mumbai 153
Melbourne 148
Dallas 138
Kent 134
Shanghai 133
São Paulo 131
Dearborn 118
San Diego 118
Naples 117
Boardman 109
Tokyo 102
Medford 92
Jakarta 88
Jacksonville 84
Toronto 82
Phoenix 79
Clifton 75
Chicago 74
Frankfurt am Main 74
Turin 74
Guangzhou 69
London 64
Bologna 59
Redondo Beach 56
Orem 55
Abuja 54
Bengaluru 50
Da Nang 49
Brooklyn 46
Montreal 46
Turku 43
Barcelona 42
Figino 42
Haiphong 41
Rio de Janeiro 41
Miano 38
Abidjan 37
Lappeenranta 36
Bari 35
Chennai 33
Tianjin 33
Brescia 32
Falls Church 32
Norwalk 32
Biên Hòa 31
Denver 31
Belo Horizonte 30
Dong Ket 30
Baghdad 28
Brasília 28
Atlanta 27
Genoa 27
Johannesburg 27
Shenzhen 27
Bern 26
Brussels 26
Mexico City 26
Pune 26
San Francisco 26
Hillsboro 25
Venice 25
Palermo 24
Stockholm 24
Totale 31.174
Salva come PNG Salva come JPEG
Nome #
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 403
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 325
The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study 317
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 316
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. 310
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 297
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 283
Role of chemotherapy in nasopharyngeal carcinoma 281
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 274
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 273
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 269
In Regard to Vaidya et al 260
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer 256
Radiosensitivity in the breast cancer management scenario: Another step forward? 254
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 248
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 245
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 242
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 240
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 238
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 237
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 231
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed 227
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 224
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 224
A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters. 223
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 223
Auto-planning for VMAT accelerated partial breast irradiation 221
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 221
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 220
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 219
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 218
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 218
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period 216
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 216
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 216
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 214
Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series 214
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 212
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 212
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 212
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 210
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 208
The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation 207
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 207
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. 206
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 206
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. 206
Role of core needle biopsy in primary breast lymphoma 204
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 201
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 201
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 200
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 199
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 199
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 198
Subcutaneous Tissue Expander Placement with Synthetic Titanium-Coated Mesh in Breast Reconstruction: Long-term Results 198
Radiotherapy in the age of cancer immunology: Current concepts and future developments 197
Accelerated Partial Breast Irradiation: Florence Phase 3 Trial Experience and Future Perspectives 195
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 195
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 194
Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: Analysis of 51 cases from a single institution and review of the literature. 194
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 193
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience 193
Cancer stem cells: biology and potential therapeutic applications 192
Thermal Ablation versus SBRT in liver tumours: pros and cons 192
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 192
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 191
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 191
A semi-automatic planning technique for whole breast irradiation with tangential IMRT fields 190
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. 190
Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting 189
A new approach in patient QA: Beam delivery check and in-vivo dosimetry during radiotherapy treatment 189
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 189
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 188
Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience. 188
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 187
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. 187
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 186
76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY 185
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 184
Impact of COVID-19 on workload burden of a complex radiotherapy facility 184
hERG1 channel expression in breast cancer: association with molecular parameters, pathological features and survival 182
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer 181
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 181
Titanium-coated polypropylene mesh as innovative bioactive material in conservatives mastectomies and pre-pectoral breast reconstruction 181
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 180
Four-dimensional computed tomography in accelerated partial breast irradiation planning: single series from a phase III trial 180
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 180
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 179
Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review 178
Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform 177
PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial 177
A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients 176
A benchmark study on 883 nasopharyngeal cancer patients treated in two ItalianCentres from 1977 to 2000. Part II: evolving technical choices and toxicitypatterns. 176
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 175
Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era? 174
The impact of young age on breast cancer outcome 174
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 174
Isolated chest wall implantation of non-small cell lung cancer after fine-needle aspiration: a case report and review of the literature. 173
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study) 173
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 172
Totale 21.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.536 0 0 139 148 44 95 48 170 80 72 271 469
2022/20234.057 390 980 167 209 251 698 526 244 392 27 106 67
2023/20241.770 73 169 259 91 127 215 92 397 45 107 135 60
2024/202512.166 416 1.211 727 1.887 3.278 1.334 325 691 694 387 508 708
2025/202618.543 1.644 2.271 1.884 1.806 1.666 583 2.161 917 1.101 1.216 877 2.417
2026/20271.860 875 836 149 0 0 0 0 0 0 0 0 0
Totale 48.573